# Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

> **NCT00802854** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 244 (actual)

## Conditions studied

- Candidemia
- Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00802854
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-02
- **Primary completion:** 2016-05-20
- **Final completion:** 2016-05-20
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802854, "Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00802854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*